CLOV Share Price Performance
US$1.72
-1.79 (-51.00%)
42.3% undervalued intrinsic discount
US$2.98
Fair Value
Price US$1.72
AnalystConsensusTarget US$2.98
AnalystHighTarget US$3.70
AnalystLowTarget US$3.00
Fair ValueUS$2.82
Share Pricen/a
Clover Health Investments, Corp. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 94 Fair Values set on narratives written by author
CLOV Community Narratives
AN
Fair Value US$2.82 38.9% undervalued intrinsic discount
Margin Pressures and Healthcare Reforms Will Influence Future Medicare Advantage Dynamics
1users have liked this narrative
0users have commented on this narrative
42users have followed this narrative
AN
Fair Value US$3.7 53.5% undervalued intrinsic discount
Digital Healthcare And Medicare Advantage Will Unlock Long-term Opportunities
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$3 42.7% undervalued intrinsic discount
Rising Costs And Regulation Will Erode Medicare Advantage Profitability
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Margin Pressures and Healthcare Reforms Will Influence Future Medicare Advantage Dynamics
Key Takeaways Technology-driven care model and data-driven tools enable lower costs, higher margins, and create new revenue opportunities amid the healthcare industry's shift toward value-based care. Focus on Medicare Advantage and efficiency improvements positions the company for sustained growth, increasing profitability, and long-term expansion.Read more
618
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
42users have followed this narrative
AN
US$2.82
38.9% undervalued intrinsic discount
Fair Value
Profit Margin
0.86%
Future PE
62.41x
Price in 2029
US$3.44
Digital Healthcare And Medicare Advantage Will Unlock Long-term Opportunities
Key Takeaways Clover's technology-driven care model and expanding platform could yield outsized membership growth, recurring revenue, and strengthened margins as competitors retreat from wide-network PPO offerings. Enhanced data access and platform initiatives may unlock significant multi-sided platform economics, positioning Clover for durable advantage amid industry shifts toward value-based reimbursement and home care.Read more
60
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$3.7
53.5% undervalued intrinsic discount
Fair Value
Profit Margin
1.37%
Future PE
48.26x
Price in 2029
US$4.52
Rising Costs And Regulation Will Erode Medicare Advantage Profitability
Key Takeaways Persistent cost pressures, regulatory risks, and rising competition threaten both profitability and scalability, undermining Clover Health's growth strategies. Heavy reliance on membership expansion and external funding increases vulnerability to market downturns and shareholder dilution.Read more
76
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$3
42.7% undervalued intrinsic discount
Fair Value
Profit Margin
0.97%
Future PE
60.62x
Price in 2029
US$3.67
Trending Discussion
Recently Updated Narratives
AN
CLOV: CMS Network Interoperability And Execution Improvements Will Support Future Upside
Fair Value: US$2.82 38.9% undervalued intrinsic discount
42 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CLOV: Patient Data Network Milestone Will Support Earnings Breakthrough Potential
Fair Value: US$3.7 53.5% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CLOV: Medicare Advantage Expansion And Buybacks Will Support Long-Term Upside
Fair Value: US$3 42.7% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Clover Health Investments, Corp. Key Details
About CLOV
- Founded
- 2014
- Employees
- 724
- CEO
- WebsiteView website
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
